ECMC Research Nurse Network Group Updates
Resource
October 2014 June 2014 February 2014 October 2013
ECMC Nurses: Embracing Challenges, Making Changes - 14 May 2014
Resource
Agenda Summary results from ECMC Survey - Sandie Wellman, Oxford (PDF) Experience and learning from a cross-centre placement - Libby Batt and Kay Wilson, Cardiff (PDF) Examples of innovative roles and practices in ECMCs: Manchester - Pamela Hindmarsh, Manchester (PDF) Examples of innovative roles and practices in ECMCs: Cambridge -...
An introduction to early phase cancer trials training day - 7 July 2014
Resource
Agenda (PDF) What is the ECMC? - Hannah Brown (PDF) Design and endpoints of Phase I/translational research - Uzma Rayani (PDF) Protocol interpretation and Screening & recruitment - Angela Little (PDF) What is translational research? - Linda Jones (PDF) Giving novel agents - Sandie Wellman & Anne Croudass (PDF) Links...
ECMC GCP Training Day - 20 November 2013
Resource
Agenda (PDF) EMA Reflection Paper - Key points and clarifications - Paul Stewart, Cancer Research UK (PDF) Computerised systems - seeing the wood from the trees - Tony Price, Manchester (PDF) Use of informatics systems to link laboratory with clinical data and ensure GCP compliance - Bill Greenhalf, Liverpool (PDF)...
ECMC QA Managers meeting - 20 March 2014
Resource
Agenda (PDF) Presentation on consent - Professor Nalin Thakker, Manchester (PDF) Presentation on serious breaches/audit findings - Dr Andrew Waddell, TMQA (PDF)
10th Anniversary Symposium of the ECMC QATS Network Group - 14 May 2014
Resource
Agenda (PDF) Reflections on the ECMC QATS Network Group - Jeff Cummings, Manchester (PDF) The new EU Clinical Trials Regulation - Paul Stewart, Cancer Research UK (PDF) Cancer Biomarkers: Hope, hype or help. Does the past predict the future? - Andrew Hughes, AstraZeneca (PDF) Molecular phenotype driven therapy for pancreatic...
Combinations Alliance EOI - Template form and guidance notes
Basic page
EOI form and guidance
Industry case studies
Basic page
ATLANTIS trial Barts-Brighton ECMC has formed a partnership around the ATLANTIS trial, a personalised therapy study of bladder cancer. In partnership with Exelixis and Astellas, BARTS ECMC will run the translational oncology biomarker part of the study, supported by a grant of £550,000. TORC 1 & 2 in breast cancer...
Terms and conditions
Basic page
Terms and Conditions 1. Definitions In the context of these terms and conditions, the following words shall have the following meanings: "ECMC Programme Office" means ECMC Programme Office, who is responsible for the content and management of the ECMC website; "Cancer Research UK" means Cancer Research UK, a charity registered...
Accessibility
Basic page
Accessibility We want everyone to be able to use our website regardless of their computer knowledge or disabilities. We have designed our website to be as accessible as possible, in accordance with guidelines laid down by the Web Accessibility Initiative (WAI). There are also some very simple services already built...